Search

Your search keyword '"Hernández Quero, José"' showing total 274 results

Search Constraints

Start Over You searched for: Author "Hernández Quero, José" Remove constraint Author: "Hernández Quero, José"
274 results on '"Hernández Quero, José"'

Search Results

3. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

4. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

7. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

8. High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world

9. Monkeypox Virus Infection and Sexually Transmitted Infections: A Cross-Sectional Study from a Secondary Hospital in the May–September 2022 International Outbreak

11. Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

15. Mpox Infection and Sexually Transmitted Infections: A Cross-Sectional Study from a Secondary Hospital in the May–September 2022 International Outbreak.

18. Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant

21. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

22. Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.

23. Comparison of High Ribavirin Induction Versus Standard Ribavirin Dosing, Plus Peginterferon-α for the Treatment of Chronic Hepatitis in HIV-Infected Patients: The PERICO Trial

25. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

26. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

27. High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

28. Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

29. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

30. New trends in infective endocarditis

32. Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial

33. Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

35. HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018

36. Update on intra-abdominal and post-surgical infections

38. Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV–HCV coinfected subjects

40. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

44. Recomendaciones españolas sobre el uso adecuado de enfuvirtida

49. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

Catalog

Books, media, physical & digital resources